Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000489536 | SCV000334423 | pathogenic | not provided | 2018-07-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000489536 | SCV000577327 | likely pathogenic | not provided | 2024-10-02 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 12461690, 12890817, 15689361, 16100770, 16141003, 15221789, 16372320, 15351423, 20635405, 14981715, 27023906, 17157502, 31980526, 31862442, 27447704, 26886200, 29970176, 35157181, 25135358, 31555977, 35894554, 36385624, 37526466, 32528171) |
Athena Diagnostics | RCV000489536 | SCV000612642 | pathogenic | not provided | 2016-10-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000311426 | SCV000830891 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-12-14 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 82 of the CAPN3 protein (p.Pro82Leu). This variant is present in population databases (no rsID available, gnomAD 0.003%). This missense change has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy (PMID: 12461690, 12890817, 15221789, 15351423, 16100770, 16141003, 16372320, 17157502, 20635405, 25135358, 26886200, 27447704). ClinVar contains an entry for this variant (Variation ID: 282783). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CAPN3 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000489536 | SCV001246423 | pathogenic | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000489536 | SCV001446731 | likely pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000489536 | SCV002018075 | pathogenic | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003475897 | SCV004211531 | pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000311426 | SCV000788754 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2016-12-15 | no assertion criteria provided | clinical testing |